热门出版物 - 学术资源搜索

h5 指数:58
h5 中位数:80

h5 指数是指在过去整整 5 年中所发表文章的 h 指数。h 指在 2018-2022 年间发表的 h 篇文章每篇至少都被引用过 h 次的最大值。隐藏

出版物的 h5 中位数，是指出版物的 h5 指数所涵盖的所有文章获得的引用次数的中位值。隐藏

#4 Transplantation
#12 Hematology

标题/作者	引用次数	年份
ASTCT Consensus Grading for Cytokine Release Syndrome and Neurologic Toxicity Associated with Immune Effector Cells DW Lee, BD Santomasso, FL Locke, A Ghobadi, CJ Turtle, JN Brudno, ... Biology of Blood and Marrow Transplantation 25 (4), 625-638	1645	2019
Current Use of and Trends in Hematopoietic Cell Transplantation in the United States A D'Souza, C Fretham, SJ Lee, M Arora, J Brunner, S Chhabra, S Devine, ... Biology of Blood and Marrow Transplantation 26 (8), e177-e182	321	2020
Cytokine Release Syndrome with Chimeric Antigen Receptor T Cell Therapy N Frey, D Porter Biology of Blood and Marrow Transplantation 25 (4), e123-e127	243	2019
Late Events after Treatment with CD19-Targeted Chimeric Antigen Receptor Modified T Cells A Cordeiro, ED Bezerra, AV Hirayama, JA Hill, QV Wu, J Voutsinas, ... Biology of Blood and Marrow Transplantation 26 (1), 26-33	193	2020
A Randomized, Double-Blind, Placebo-Controlled Phase 3 Trial of Oral Brincidofovir for Cytomegalovirus Prophylaxis in Allogeneic Hematopoietic Cell Transplantation FM Marty, DJ Winston, RF Chemaly, KM Mullane, TB Shore, ... Biology of Blood and Marrow Transplantation 25 (2), 369-381	163	2019
Burnout, Moral Distress, Work–Life Balance, and Career Satisfaction among Hematopoietic Cell Transplantation Professionals JL Neumann, LW Mau, S Virani, EM Denzen, DA Boyle, NJ Boyle, ... Biology of Blood and Marrow Transplantation 24 (4), 849-860	149	2018
Significant Risk of Graft-versus-Host Disease with Exposure to Checkpoint Inhibitors before and after Allogeneic Transplantation A Ijaz, AY Khan, SU Malik, W Faridi, MA Fraz, M Usman, MJ Tariq, S Durer, ... Biology of Blood and Marrow Transplantation 25 (1), 94-99	140	2019
Indications for Hematopoietic Cell Transplantation and Immune Effector Cell Therapy: Guidelines from the American Society for Transplantation and Cellular Therapy AS Kanate, NS Majhail, BN Savani, C Bredeson, RE Champlin, ... Biology of Blood and Marrow Transplantation 26 (7), 1247-1256	135	2020
Complement Blockade for TA-TMA: Lessons Learned from Large Pediatric Cohort Treated with Eculizumab S Jodele, CE Dandoy, A Lane, B Laskin, A Teusink-Cross, KC Myers, ... Biology of Blood and Marrow Transplantation 26 (3), S138	134	2020
Use of Chimeric Antigen Receptor T Cell Therapy in Clinical Practice for Relapsed/Refractory Aggressive B Cell Non-Hodgkin Lymphoma: An Expert Panel Opinion from the American Society for Transplantation and Cellular Therapy T Jain, M Bar, AJ Kansagra, EA Chong, SK Hashmi, SS Neelapu, M Byrne, ... Biology of Blood and Marrow Transplantation 25 (12), 2305-2321	133	2019
Autologous Transplantation in Follicular Lymphoma with Early Therapy Failure: A National LymphoCare Study and Center for International Blood and Marrow Transplant Research Analysis C Casulo, JW Friedberg, KW Ahn, C Flowers, A DiGilio, SM Smith, ... Biology of Blood and Marrow Transplantation 24 (6), 1163-1171	128	2018
Hematopoietic Stem Cell Transplantation for Mucopolysaccharidoses: Past, Present, and Future M Taylor, S Khan, M Stapleton, J Wang, J Chen, R Wynn, H Yabe, ... Biology of Blood and Marrow Transplantation 25 (7), e226-e246	118	2019
Risk Factors for Development of and Progression of Hepatic Veno-Occlusive Disease/Sinusoidal Obstruction Syndrome S Corbacioglu, EJ Jabbour, M Mohty Biology of Blood and Marrow Transplantation 25 (7), 1271-1280	117	2019
CC-486 Maintenance after Stem Cell Transplantation in Patients with Acute Myeloid Leukemia or Myelodysplastic Syndromes M de Lima, B Oran, RE Champlin, EB Papadopoulos, SA Giralt, BL Scott, ... Biology of Blood and Marrow Transplantation 24 (10), 2017-2024	116	2018
Haploidentical Bone Marrow Transplantation with Post-Transplantation Cyclophosphamide Plus Thiotepa Improves Donor Engraftment in Patients with Sickle Cell Anemia: Results of an International Learning Collaborative J de la Fuente, N Dhedin, T Koyama, F Bernaudin, M Kuentz, L Karnik, ... Biology of Blood and Marrow Transplantation 25 (6), 1197-1209	114	2019
A Phase 3 Randomized Study of Remestemcel-L versus Placebo Added to Second-Line Therapy in Patients with Steroid-Refractory Acute Graft-versus-Host Disease P Kebriaei, J Hayes, A Daly, J Uberti, DI Marks, R Soiffer, EK Waller, ... Biology of Blood and Marrow Transplantation 26 (5), 835-844	107	2020
Development of an Unrelated Donor Selection Score Predictive of Survival after HCT: Donor Age Matters Most BE Shaw, BR Logan, SR Spellman, SGE Marsh, J Robinson, J Pidala, ... Biology of Blood and Marrow Transplantation 24 (5), 1049-1056	100	2018
A Phase 3, Single-Arm, Prospective Study of Remestemcel-L, Ex Vivo Culture-Expanded Adult Human Mesenchymal Stromal Cells for the Treatment of Pediatric Patients Who Failed to Respond to Steroid Treatment for Acute Graft-versus-Host Disease J Kurtzberg, H Abdel-Azim, P Carpenter, S Chaudhury, B Horn, ... Biology of Blood and Marrow Transplantation 26 (5), 845-854	96	2020
Clinical Utilization of Chimeric Antigen Receptor T Cells in B Cell Acute Lymphoblastic Leukemia: An Expert Opinion from the European Society for Blood and Marrow Transplantation and the American Society for Transplantation and Cellular Therapy AJ Kansagra, NV Frey, M Bar, TW Laetsch, PA Carpenter, BN Savani, ... Biology of Blood and Marrow Transplantation 25 (3), e76-e85	94	2019
Cardiac Profile of Chimeric Antigen Receptor T Cell Therapy in Children: A Single-Institution Experience DS Burstein, S Maude, S Grupp, H Griffis, J Rossano, K Lin Biology of Blood and Marrow Transplantation 24 (8), 1590-1595	91	2018

1 - 20

计算机程序会自动估算并确定日期和引用次数。